Understanding and targeting the disease‐related RNA binding protein human antigen R (HuR)
Altered gene expression is a characteristic feature of many disease states such as
tumorigenesis, and in most cancers, it facilitates cancer cell survival and adaptation …
tumorigenesis, and in most cancers, it facilitates cancer cell survival and adaptation …
Journey of siRNA: clinical developments and targeted delivery
RR Nikam, KR Gore - Nucleic acid therapeutics, 2018 - liebertpub.com
Since the evolutionary discovery of RNA interference and its utilization for gene knockdown
in mammalian cell, a remarkable progress has been achieved in small interfering RNA …
in mammalian cell, a remarkable progress has been achieved in small interfering RNA …
Self‐assembled peptide‐based nanodrugs: molecular design, synthesis, functionalization, and targeted tumor bioimaging and biotherapy
Functional nanomaterials as nanodrugs based on the self‐assembly of inorganics,
polymers, and biomolecules have showed wide applications in biomedicine and tissue …
polymers, and biomolecules have showed wide applications in biomedicine and tissue …
Current aspects of siRNA bioconjugate for in vitro and in vivo delivery
W Tai - Molecules, 2019 - mdpi.com
Studies on siRNA delivery have seen intense growth in the past decades since siRNA has
emerged as a new class of gene therapeutics for the treatment of various diseases. siRNA …
emerged as a new class of gene therapeutics for the treatment of various diseases. siRNA …
[HTML][HTML] Peptide-based delivery of therapeutics in cancer treatment
T Samec, J Boulos, S Gilmore, A Hazelton… - Materials Today Bio, 2022 - Elsevier
Current delivery strategies for cancer therapeutics commonly cause significant systemic side
effects due to required high doses of therapeutic, inefficient cellular uptake of drug, and poor …
effects due to required high doses of therapeutic, inefficient cellular uptake of drug, and poor …
A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications
Introduction RNA interference (RNAi) using small interfering RNA (siRNA) is a promising
strategy to control many genetic disorders by targeting the mRNA of underlying genes and …
strategy to control many genetic disorders by targeting the mRNA of underlying genes and …
Transition‐Metal‐Mediated Modification of Biomolecules
J Rodríguez, M Martínez‐Calvo - Chemistry–A European …, 2020 - Wiley Online Library
The site‐selective modification of biomolecules has grown spectacularly in recent years. The
presence of a large number of functional groups in a biomolecule makes its chemo‐and …
presence of a large number of functional groups in a biomolecule makes its chemo‐and …
Materialistic interfaces with nucleic acids: principles and their impact
BL Li, H Zhang, NB Li, H Qian… - Advanced Functional …, 2022 - Wiley Online Library
Mendelian genetics spark the century‐old revolution in genetic engineering. DNA structural
engineering may well spark a similar revolution in chemistry. The first few man‐made DNA …
engineering may well spark a similar revolution in chemistry. The first few man‐made DNA …
Peptides, polypeptides and peptide–polymer hybrids as nucleic acid carriers
M Ahmed - Biomaterials science, 2017 - pubs.rsc.org
Cell penetrating peptides (CPPs), and protein transduction domains (PTDs) of viruses and
other natural proteins serve as a template for the development of efficient peptide based …
other natural proteins serve as a template for the development of efficient peptide based …
Lipid and peptide-oligonucleotide conjugates for therapeutic purposes: from simple hybrids to complex multifunctional assemblies
Antisense and small interfering RNA (siRNA) oligonucleotides have been recognized as
powerful therapeutic compounds for targeting mRNAs and inducing their degradation …
powerful therapeutic compounds for targeting mRNAs and inducing their degradation …